Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06618027 · ClinicalTrials.gov registry record · NA
Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concerns in Youth With Type 1 Diabetes
A NA study of Type 1 Diabetes (T1D), sponsored by Children's National Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 2
- Study locations
NCT06618027: Recruiting NA study of Type 1 Diabetes (T1D), sponsored by Children's National Research Institute.
NCT06618027 is a NA study of Type 1 Diabetes (T1D) that is actively recruiting participants, run by Children's National Research Institute. The registered enrollment target is 200 participants, above the 169-participant average among 17 other Type 1 Diabetes (T1D) trials with a reported enrollment target (18% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06618027, a NA study of Type 1 Diabetes (T1D), is actively recruiting participants, sponsored by Children's National Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
Type 1 diabetes (T1D) is a common chronic illness among children requiring a high degree of self-management for good glycemic control. Adolescents are at risk for poor disease management and health outcomes due to a number of factors, including high rates of depression, anxiety, and stress. Accessing support for these challenges can be a barrier to care, so the current study, BRinging Empowerment and Attention to Teen HEalth-T1D, evaluates the efficacy of a virtual, group-based mindfulness based intervention and a virtual group-based diabetes education intervention on improving symptoms of depression and anxiety, and diabetes self management in teens with T1D. The study also aims to study how these interventions might be implemented in diabetes clinic settings.
Primary Outcome
Glycemic control will be measured by at home hemoglobin A1c kits as well as downloads of continuous glucose monitor or blood glucose meter data across a 2 week period, with percent of time in range (70-180) calculated and HbA1c used as an indicator of glycemic control over the prior 3 months.
Conditions Studied
Interventions
- BEHAVIORAL BREATHE-T1D
- BEHAVIORAL HealthEd-T1D
Study Locations (2)
Colorado
- Barbara Davis Center - Aurora
District of Columbia
- Children's National Hospital - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-05-15 |
| Est. Completion | 2029-08-06 |
| Phase | NA |
What NCT06618027 shows while recruiting
NCT06618027 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 169-participant average among 17 other Type 1 Diabetes (T1D) trials with a reported enrollment target (18% higher).
The record links to 1 condition, with Type 1 Diabetes (T1D) appearing as the primary indexed condition, and to 2 interventions - of which BREATHE-T1D is the first listed.
NCT06618027 reports a single indexed study location in Colorado, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT06618027 about?
NCT06618027 is a clinical study titled "Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concerns in Youth With Type 1 Diabetes". Type 1 diabetes (T1D) is a common chronic illness among children requiring a high degree of self-management for good glycemic control. Adolescents are at risk for poor disease management and health outcomes due to a number of factors, including high rates of depression, anxiety, and stress. Accessin...
What is the current status of trial NCT06618027?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-05-15. Estimated completion is 2029-08-06.
What conditions does trial NCT06618027 study?
This clinical trial studies the following conditions: Type 1 Diabetes (T1D).
What interventions are being tested in trial NCT06618027?
The interventions under investigation include: BREATHE-T1D (BEHAVIORAL), HealthEd-T1D (BEHAVIORAL).
Who is sponsoring clinical trial NCT06618027?
This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06618027 being conducted?
This trial has 2 study locations across Colorado, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes (T1D)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06618027's enrollment target sits among peer trials
200 3rd of 17 higher than 15 of 17 other Type 1 Diabetes (T1D) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 1 Diabetes (T1D) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes
RECRUITING · NA
-
Circadian Mechanisms, Glucose, and CV Risks in T1D
RECRUITING · NA
-
Automated Insulin for Management of Intrapartum Glycemia
RECRUITING · NA
-
Digital Mindfulness for Young Adults With Type 1 Diabetes
RECRUITING · NA
-
Utilizing Community Health Workers as Diabetes Technology Coaches for Children With Type 1 Diabetes Using Automated Insulin Delivery
RECRUITING · NA
-
Type 1 Diabetes and Obstructive Sleep Apnea
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI